Two dimensional view of combination chemotherapy in vitro

A newly developed micromethod to evaluate the cytotoxic effects of drugs on rapidly growing lymphoid cell lines is described, which permits evaluation of more than one variable. This technique allows a checkerboard titration of two drugs to determine the optimum concentration of each needed for the augmentation of the other's cell‐killing activity. Such studies have shown that the minimum concentration of vincristine capable of killing a human lymphoid cell population is 5.6 ng/ml. The addition of prednisolone at a concentration of 460 ng/ml reduces the minimum lethal concentration of vincristine to 1.6 ng/ml. When prednisolone is added to vincristine at concentrations of 2.8 μ/ml (a level readily achieved in the serum in vivo) concentrations of vincristine as low as 200 pg/ml are clearly cytotoxic. Similar potentiation of cytotoxicity following the addition of prednisolone has been demonstrated for cytosine arabinoside, but not for daunorubicin and only slightly for methotrexate. The micromethod for the study of optimal doses to be used in drug combinations is simple and gives highly reproducible results. It should be of considerable utility to anyone interested in screening a wide variety of drug concentrations for augmentation or synergistic effects.

[1]  P. N. Rao,et al.  Schedule-dependent synergistic cytotoxicity of arabinofuranosylcytosine with adriamycin or 3,6-bis(5-chloro-2-piperidinyl)-2,5-piperazinedione in cultured cells. , 1975, Cancer research.

[2]  Y. Hirshaut,et al.  In vitro combination chemotherapy demonstrating potentiation of vincristine cytotoxicity by prednisolone. , 1975, Cancer research.

[3]  M. L. Smith,et al.  In Vitro Evaluation of 1-β-D-Arabinofuranosylcytosine-β-2-Deoxythioguanosine Combination Chemotherapy , 1974 .

[4]  R. Schrek.  Cytotoxicity of Vincristine to Normal and Leukemic Cells , 1974 .

[5]  T. J. Fraser,et al.  Antagonism between DNA synthesis inhibitors and protein synthesis inhibitors in mammalian cell cultures. , 1974, Cancer research.

[6]  E. Freireich,et al.  Lethal activity of camptothecin sodium on human lymphoma cells. , 1974, Cancer research.

[7]  B. Brown,et al.  The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications. , 1973, Cancer research.

[8]  B. Brown,et al.  The response of synchronized human lymphoma cells to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1973, Cancer research.

[9]  T. A. Connors,et al.  Combination chemotherapy: the interaction of methotrexate and 5-fluorouracil. , 1973, European journal of cancer.

[10]  J. Peacock,et al.  Action of actinomycin D, bleomycin and x rays on HeLa cells. , 1973, The British journal of radiology.

[11]  V. Oliverio,et al.  The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia. , 1973, Cancer research.

[12]  S. Kuentzel,et al.  Cell-kill kinetics of several S-phase-specific drugs. , 1973, Cancer research.

[13]  B. Drewinko,et al.  The effects of arabinosylcytosine on cultured human lymphoma cells. , 1972, Cancer research.

[14]  B. Drewinko,et al.  The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1972, Cancer research.

[15]  T. J. Fraser,et al.  Cell cycle phase specificity of antitumor agents. , 1972, Cancer research.

[16]  W. Dolowy,et al.  In vitro test for sensitivity of leukemic cells to L-asparaginase. , 1971, Cancer research.

[17]  S. Killmann,et al.  Perturbation of generation cycle of human leukemic blast cells by cytostatic therapy in vivo: effect of corticosteroids. , 1970, Blood.

[18]  H. Madoc‐Jones,et al.  Age responses of cultured mammalian cells to cytotoxic drugs. , 1970, Cancer research.

[19]  S. Perry,et al.  The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents. , 1969, Cancer research.

[20]  G. Whitmore,et al.  Cell killing studies on the mode of action of methotrexate on L-cells in vitro. , 1969, Cancer research.

[21]  W. R. Bruce,et al.  An in vitro assay for growth-inhibiting activity of vinblastine. , 1965, Journal of the National Cancer Institute.

[22]  N. Bruchovsky,et al.  Effects of vinblastine on the proliferative capacity of L cells and their progress through the division cycle. , 1965, Cancer research.

[23]  R. Schrek.  PREDNISOLONE SENSITIVITY AND CYTOLOGY OF VIABLE LYMPHOCYTES AS TESTS FOR CHRONIC LYMPHOCYTIC LEUKEMIA. , 1964, Journal of the National Cancer Institute.

[24]  I. Toplin.  Experiences with the tissue culture system in large-scale cancer chemotherapy screening. , 1961, Cancer research.

[25]  H. Eagle,et al.  Cytotoxicity in human cell cultures as a primary screen for the detection of anti-tumor agents. , 1958, Cancer research.